Electric shocks plus chemo: a new way to fight melanoma?

NCT ID NCT07404605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how electrochemotherapy—a treatment that uses electric pulses to help chemotherapy drugs enter cancer cells—changes the environment around melanoma skin tumors. Researchers will collect tissue samples from 150 adults before and after treatment to see how immune cells and blood vessels in the tumors respond. The goal is to better understand why this treatment works and how it might be improved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bleomycin or cisplatin (chemotherapy drugs) combined with electric pulses
What this could lead to
If successful, this study could reveal how electrochemotherapy boosts the immune response against melanoma, potentially leading to better combination treatments.
What could go wrong
This is an early-stage observational study focused on biological changes, not on curing the disease. The results may not directly translate into new treatments or benefit participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.